Skip to main content
Clinical Trials/NL-OMON30726
NL-OMON30726
Recruiting
Not Applicable

A new design metal stent, SX-Ella stent Esophageal HV, for the prevention of recurrent dysphagia due to migration or tissue overgrowth: a prospective follow-up study - SX-ELLA stent Esophageal HV for the prevention of recurent dysphagia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a.Inoperable malignant obstruction of the esophagus or cardia (a tumor is considered inoperable if the patient has local tumor infiltration in neighboring organs, distant metastases, or a poor general health due to serious concomitant disease).
  • b.Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal cancer.
  • c.Signed informed consent.

Exclusion Criteria

  • a.Evidence of tumor within 2 cm of the upper esophageal sphincter.
  • b.Esophagotracheal or \-bronchial fistula or both.
  • c.Lesions longer than 12 cm.
  • d.WHO performance score of 4\.
  • e.Lack of fitness for sedation (including known allergies).

Outcomes

Primary Outcomes

Not specified

Similar Trials